Last update: March 24, 2015
Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Midecamycin is also known as
Midecamycin belongs to this group or family:
Main tradenames from several countries containing Midecamycin in its composition:
Variable | Value | Unit |
---|---|---|
Molecular weight | 814 | daltons |
Protein Binding | 47 | % |
Tmax | 0,5 - 1 | hours |
T1/2 | 1 - 3 | hours |
Write to us at elactancia.org@gmail.com
e-lactancia is a resource recommended by La Liga de la Leche de Euskadi
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
It is a Macrolide-type antibiotic.
At latest update, relevant published data on excretion into breast milk were not found.
A high molecular weight makes excretion into breast milk be very unlikely.
Until more data on this medication is available, safer alternative drugs are preferred, especially in such critical age periods.
Be aware of false negative results of bacterial cultures from febrile infants, that may occur when breastfeeding mothers are taking antibiotics.